18+

CELLIVITY / ADULT ACCESS

Are you 18 or older?

CELLIVITY is available to adults only. Supplement pages are general product information; peptide records are not a sales offer and are not for human use.

Age confirmation is a declaration, not identity verification. Restricted research access still requires separate professional eligibility checks.Privacy and legal notice ↗
Skip to content
CELLIVITY
Supplements
Peptides⌄
Research areasAll Peptides→Metabolic→Recovery→Nootropic→Energy→Aesthetics→Neuron→
Peptide calculatorAbout CELLIVITY
Featured productsRetatrutide฿3,700BPC-157฿1,300MOTS-c฿1,500GHK-Cu฿1,400
CalculatorScienceAbout Us
🇬🇧EN⌄
🇬🇧EnglishEN🇭🇺MagyarHU🇹🇭ไทยTH🇷🇺РусскийRU
Browse products ↗○LoginCart0
Supplements
Peptides+
All PeptidesMetabolicRecoveryNootropicEnergyAestheticsNeuronPeptide calculatorRetatrutide฿3,700BPC-157฿1,300MOTS-c฿1,500GHK-Cu฿1,400
Calculator↗ScienceAbout UsLogin / Create accountBrowse products
Currency
Thailand retail pricesProduct laboratory references18+ access
Peptides/GHK-Cu
GHK-Cu — CELLIVITYOpen full-size image ↗
Packaging concept; the selected format is shown below.Selected format: 50 mg
CELLIVITY PEPTIDE LABS · CEL-P-GHK-001

GHK-Cu

Copper-peptide research material; route-specific format not yet released

For laboratory research only · Not intended for human or veterinary use.

Select format
THAILAND LAUNCH PRICE฿1,40050 mg · per vial · tax and delivery confirmed at enquiry
Sourced on enquiry · lead time confirmed individuallyAvailability is confirmed for this exact format before any commitment.
1
Selected50 mg · 1 vial · ฿1,400
Check availability ↗
Product reference filesQuality reviewThailand support
Product record
CEL-P-GHK-001
Reference files
1 · CELLIVITY lot review pending
Product details ↓Lab documents (1) ↓Delivery ↓Check availability ↓
Lab documents

PRODUCT DESCRIPTION

GHK-Cu,
made legible.

GHK-Cu is a complex formed by the tripeptide GHK and copper. It is studied in skin and extracellular-matrix biology, but topical cosmetic evidence and injectable-material questions are different evidence tracks and must not be blended together.

Research focus

Copper-binding peptide biology in extracellular-matrix and skin models.

Current evidence context

Laboratory and topical-formulation findings do not establish systemic or injectable benefit. Human evidence is route- and formulation-specific, and injectable safety data are limited.

Questions this record follows

  • What proportion of the material is the intended copper-peptide complex?
  • Which matrix and skin-model findings reproduce in controlled studies?
  • How do topical and parenteral routes differ in exposure, quality requirements and risk?
Evidence boundaryRoute, copper exposure, sterility and product identity materially change both the evidence and the risk.

Follow the sources

Registry entries identify reference substances. Literature links describe research and do not certify this product or its batch.

  • Literature searchGHK-Cu human — PubMed research index ↗

04 — LAB RESULTS & DOCUMENTS

One product. One place. One evidence trail.

Exact CELLIVITY-batch review is pending. Reference files below describe their own declared samples.

Purity, identity, per-vial content and sterility are separate results.

Product
GHK-Cu
Record
CEL-P-GHK-001
Files received
1
GHK-Cu 100 mg analytical report — original uploaded document
DOCUMENT RECEIVED · REVIEW PENDING

GHK-Cu 100 mg analytical report

Report image shows 106.30 mg measured content and 99.969% purity.

Source
Janoshik Analytical / Cocer Peptides reference sample
Document type
Third-party analytical report
Sample
GHK-Cu 100 mg
Declared lot
CS-gu100715
Report date
25 Jul 2025
Review state
Received — CELLIVITY review pending
Open original image ↗

AVAILABILITY

Tell us what
your lab needs.

Request current availability for a lawful institutional, analytical or laboratory purpose. We confirm the exact presentation, price, batch and document state before any next step.

  • Exact presentation review
  • Jurisdiction and purpose check
  • Batch-document confirmation
  • No medical or human-use guidance
SELECTED PRODUCTGHK-CuCEL-P-GHK-001 · response after manual review

GHK-Cu · 50 mg × 1

GHK-Cu: before you enquire

What exactly does the selected format mean?+

The mg or IU value is the declared material content per vial; it is not the container volume. Your selected presentation and quantity are saved with your enquiry. The final price is confirmed in the response.

Which batch will be supplied?+

The specific batch and its documents are confirmed in the response. Files shown here may be supplier reference samples; the current record does not yet contain a qualified CELLIVITY lot dossier.

When can it arrive in Thailand?+

For confirmed local stock, the planned window is 2–3 working days in Thailand. Pattaya timing is agreed directly. Incoming or specially sourced products have a separate estimate, confirmed before a commitment.

Can I enquire about several products together?+

Yes. Add each format and quantity to the cart, then send one availability enquiry. Your selected items are kept together for review.

CELLIVITY

GHK-Cu

CEL-P-GHK-001 · 50 mg / 100 mg

GHK-Cu is a complex formed by the tripeptide GHK and copper. It is studied in skin and extracellular-matrix biology, but topical cosmetic evidence and injectable-material questions are different evidence tracks and must not be blended together.

Copper-binding peptide biology in extracellular-matrix and skin models.

Other names
GHK-Cu · copper tripeptide
Compound class
Copper-GHK coordination complex; exact copper-to-GHK stoichiometry pending

Follow the sources

Laboratory and topical-formulation findings do not establish systemic or injectable benefit. Human evidence is route- and formulation-specific, and injectable safety data are limited.

  • What proportion of the material is the intended copper-peptide complex?
  • Which matrix and skin-model findings reproduce in controlled studies?
  • How do topical and parenteral routes differ in exposure, quality requirements and risk?

Lab documents

CELLIVITY lot review pending

  • GHK-Cu 100 mg analytical report · 25 Jul 2025 · CS-gu100715

Route, copper exposure, sterility and product identity materially change both the evidence and the risk.

CELLIVITY · cellivity@gmail.com

← Back to collection
CELLIVITY

Your future is cellular.

SupplementsSupplementsPeptidesAbout Us
Product statusLaunch updatesLab document libraryPeptide dossier index
CELLIVITYAbout UsLanguagesSafetyContact
LegalMedical disclaimerPrivacyPrivacy request / unsubscribeTerms
Laboratory catalogue

18+ access. Peptide records support lawful laboratory enquiries only. Exact availability and lot documents are confirmed separately; no human or veterinary use instructions are provided.

Delivery, storage and responsibility

Delivery method, fees and the committed timeframe are set out in the accepted quotation. Delays or damage are handled with the recipient; CELLIVITY remains responsible for its agreed packaging and fulfilment. After receipt, the recipient must follow the documented storage conditions for the specific batch and report deviations. Research materials are intended for lawful work in an appropriate professional setting, not human or veterinary self-use. These terms do not exclude statutory liability or mandatory customer rights.

Full research-use terms →
© 2026 CELLIVITY. Pre-launch.Riviera Jomtien, 29/111, Pattaya 20150, ThailandControlled contact route

CELLIVITY / STAY IN THE LOOP

Follow the next
chapter.

New product records, laboratory documents and release news. Choose to hear from us when there is something useful to share.

  • New laboratory documents
  • Product availability updates
  • News from CELLIVITY
18+ only. Optional email updates. You can unsubscribe at any time.
GHK-Cu research dossier — CELLIVITY